Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: Differences in phenotype and prognostic impact

A. Tefferi, T. L. Lasho, C. Finke, A. A. Belachew, E. A. Wassie, R. P. Ketterling, C. A. Hanson, A. Pardanani

Research output: Contribution to journalLetter

108 Scopus citations
Original languageEnglish (US)
Pages (from-to)1568-1570
Number of pages3
JournalLeukemia
Volume28
Issue number7
DOIs
StatePublished - Jul 2014

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Tefferi, A., Lasho, T. L., Finke, C., Belachew, A. A., Wassie, E. A., Ketterling, R. P., Hanson, C. A., & Pardanani, A. (2014). Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: Differences in phenotype and prognostic impact. Leukemia, 28(7), 1568-1570. https://doi.org/10.1038/leu.2014.83